Investigation of cytochrome p450 isoforms 1A1, 1B1 and 2W1 as targets for therapeutic intervention in head and neck cancer. Probing CYP1A1, 1B1 and 2W1 activity with duocarmycin bioprecursors
dc.contributor.advisor | Patterson, Laurence H. | |
dc.contributor.advisor | McCaul, Jim | |
dc.contributor.advisor | Pors, Klaus | |
dc.contributor.author | Presa, Daniela | |
dc.date.accessioned | 2020-11-18T12:15:18Z | |
dc.date.available | 2020-11-18T12:15:18Z | |
dc.date.issued | 2018 | |
dc.identifier.uri | http://hdl.handle.net/10454/18171 | |
dc.language.iso | en | en_US |
dc.rights | <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><img alt="Creative Commons License" style="border-width:0" src="http://i.creativecommons.org/l/by-nc-nd/3.0/88x31.png" /></a><br />The University of Bradford theses are licenced under a <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Licence</a>. | en_US |
dc.subject | Cytochrome P450 (CYP) | en_US |
dc.subject | CYP1A1 | en_US |
dc.subject | CYP1B1 | en_US |
dc.subject | CYP2W1 | en_US |
dc.subject | Head and Neck Cancer (HNC) | en_US |
dc.subject | Duocarmycin | en_US |
dc.subject | Prodrug | en_US |
dc.subject | Bioprecursor | en_US |
dc.subject | DNA damage | en_US |
dc.subject | Therapeutic intervention | en_US |
dc.title | Investigation of cytochrome p450 isoforms 1A1, 1B1 and 2W1 as targets for therapeutic intervention in head and neck cancer. Probing CYP1A1, 1B1 and 2W1 activity with duocarmycin bioprecursors | en |
dc.type.qualificationlevel | doctoral | en_US |
dc.publisher.institution | University of Bradford | eng |
dc.publisher.department | Institute of Cancer Therapeutics, Faculty of Life Sciences | en_US |
dc.type | Thesis | eng |
dc.type.qualificationname | PhD | en_US |
dc.date.awarded | 2018 | |
dc.description.publicnotes | The full text will be available at the end of the embargo: 30th July 2026 | en |
refterms.dateFOA | 2020-11-18T12:15:19Z | |
dc.date.endofembargo | 2026-07-30 |